Mindfulness meditation for improving cognition in older adults

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to investigate the effects of mindfulness meditation on cognitive outcomes in older adults, including those with mild cognitive impairment and healthy elderly individuals. Participants will be randomly assigned to either a mindfulness intervention group or a waitlist control group, allowing researchers to compare cognitive performance, brain function, and quality of life between the two groups. The study seeks to determine how mindfulness practices can influence thinking, memory, and daily functioning in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Healthy older adults will show cognitive performance within 1.0 SD for age \& education adjusted norms on a neuropsychological test battery
* Mild cognitive impairment (MCI) participants will show performance on delayed recall or one more or more other cognitive domains worse than 1.5 SD for age \& education adjusted norms, an MMSE score between 25-30, and a MoCA score between 20-30.

Exclusion Criteria:

* Participants without a computer, smart phone and internet access will be excluded
* If they cannot understand the informed consent form or have moderate dementia.
* Mood disorders (e.g., PTSD, depression, anxiety) or alcohol and drug use that either interferes with day-to-day life or required hospitalization within the past 5 years
* Cerebrovascular disease
* Any medical condition whose severity could significantly impair cognition (e.g., stroke, frontotermporal dementia, Parkinson's disease) are exclusionary

Where it's running

• VA Boston Healthcare System - Jamaica Plain Campus
  Boston, Massachusetts, United States Recruiting

Study contacts

• Study coordinator: Katherine W Turk, MD
• Email: ctcnbrainlab@gmail.com
• Phone: 8573645429

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using deep rTMS to improve memory in Alzheimer's Disease

  This study is testing if a new brain treatment called deep rTMS can help improve memory in people with mild to moderate Alzheimer's Disease.

  Recruiting Phase 1/2 University of California, Los Angeles · Los Angeles, California · NCT06597942

• LIFU to Help Sleep and Amyloid Reduction in Older Adults with Cognitive Impairment

  A wearable ultrasound device (ATTN201) is being tested to see if it’s safe and easy to use for people 65 and older with mild cognitive impairment and amyloid buildup.

  Recruiting University of California, San Francisco · San Francisco, California · NCT07866768

• Digital STEADI: A home-based digital fall prevention program for older adults

  A home-based digital program using AI-driven conversational agents tests if a guided fall-prevention exercise plan can reduce fall risk for older adults with mild cognitive impairment living independently.

  Recruiting Phase 1/2 Friendi.fi Corporation · Atlanta, Georgia · NCT07852650

• Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns

  This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.

  Recruiting University of Cambridge · Cambridge, CB2 · NCT07786116

• Twice-daily digital exercises to improve working memory and control in older adults

  This study tests whether two different digital training apps, used about 25–45 minutes a day for up to eight weeks, can help older adults (including those with mild cognitive impairment) improve working memory and inhibitory control.

  Recruiting University of California, San Francisco · San Francisco, California · NCT06918704

• Using ctDNA to guide chemotherapy for elderly colon cancer patients after surgery

  This study tests if using a blood test to check for cancer DNA can help doctors decide the best chemotherapy for older patients with high-risk colon cancer after surgery.

  Recruiting Phase 3 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06609551

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.